BioArctic AB (BRCTF)
35.00
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
BioArctic Shareholders Equity (Quarterly) : 230.74M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 230.74M |
| December 31, 2025 | 213.38M |
| September 30, 2025 | 209.38M |
| June 30, 2025 | 213.64M |
| March 31, 2025 | 192.53M |
| December 31, 2024 | 81.00M |
| September 30, 2024 | 90.63M |
| June 30, 2024 | 87.76M |
| March 31, 2024 | 92.84M |
| December 31, 2023 | 103.85M |
| September 30, 2023 | 103.89M |
| June 30, 2023 | 92.03M |
| March 31, 2023 | 104.67M |
| December 31, 2022 | 75.46M |
| September 30, 2022 | 75.46M |
| June 30, 2022 | 68.31M |
| March 31, 2022 | 79.95M |
| December 31, 2021 | 87.11M |
| September 30, 2021 | 92.26M |
| June 30, 2021 | 98.73M |
| Date | Value |
|---|---|
| March 31, 2021 | 100.80M |
| December 31, 2020 | 110.48M |
| September 30, 2020 | 102.81M |
| June 30, 2020 | 100.95M |
| March 31, 2020 | 98.75M |
| December 31, 2019 | 104.10M |
| September 30, 2019 | 100.82M |
| June 30, 2019 | 107.73M |
| March 31, 2019 | 111.19M |
| December 31, 2018 | 114.79M |
| September 30, 2018 | 76.75M |
| June 30, 2018 | 73.40M |
| March 31, 2018 | 77.80M |
| December 31, 2017 | 77.70M |
| September 30, 2017 | 7.851M |
| June 30, 2017 | 7.611M |
| March 31, 2017 | |
| December 31, 2016 | 6.688M |
| September 30, 2016 | 10.61M |
| June 30, 2016 | 11.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Hansa Biopharma AB | -28.90M |
| Swedish Orphan Biovitrum AB | 4.238B |
| Diamyd Medical AB | 18.82M |
| BONESUPPORT HOLDING AB | 98.56M |
| BioInvent International AB | 46.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 281.25M |
| Total Liabilities (Quarterly) | 50.51M |
| Debt to Equity Ratio | 0.0185 |
| Current Ratio | 6.538 |
| Net Debt Paydown Yield | 0.00% |